Because BDCA1+CD14+ cells were observed in melanoma and ovarian cancer, we hypothesize that BDCA1+CD14+ cells are present in a broad spectrum of cancers and that further research on their presence, generation, and biology may reveal new treatment opportunities and/or improvements for DC cancer immunotherapy. The gene discussed is CD1C; the disease is melanoma.